Co-exposure to gamma-hydroxybutyrate is associated with attenuated neuropsychiatric and stimulant effects of metamfetamine

References

• Greene SL, Kerr F, Braitberg G. Review article: amphetamines and related drugs of abuse. Emerg Med Australas. 2008;20(5):391–402. doi: 10.1111/j.1742-6723.2008.01114.x.
   PubMed Web of Science ®Google Scholar
• Weiss SR, Raskind R, Morganstern NL, et al. Intracerebral and subarachnoid hemorrhage following use of methamphetamine ("speed"). Int Surg. 1970;53(2):123–127.
   PubMedGoogle Scholar
• Callaway CW, Clark RF. Hyperthermia in psychostimulant overdose. Ann Emerg Med. 1994;24(1):68–76. doi: 10.1016/s0196-0644(94)70165-2.
   PubMed Web of Science ®Google Scholar
• Ginsberg MD, Hertzman M, Schmidt-Nowara WW. Amphetamine intoxication with coagulopathy, hyperthermia, and reversible renal failure. A syndrome resembling heatstroke. Ann Intern Med. 1970;73(1):81–85. doi: 10.7326/0003-4819-73-1-81.
   PubMed Web of Science ®Google Scholar
• Harnett JT, Dargan PI, Dines AM, et al. Increasing emergency department attendances in Central london with methamphetamine toxicity and associated harms. Emerg Med J. 2022;39(6):463–466. doi: 10.1136/emermed-2020-209550.
   PubMed Web of Science ®Google Scholar
• Richards JR, Albertson TE, Derlet RW, et al. Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review. Drug Alcohol Depend. 2015;150:1–13. doi: 10.1016/j.drugalcdep.2015.01.040.
   PubMed Web of Science ®Google Scholar
• Wodarz N, Krampe-Scheidler A, Christ M, et al. Evidence-based guidelines for the pharmacological management of acute methamphetamine-related disorders and toxicity. Pharmacopsychiatry. 2017;50(3):87–95. doi: 10.1055/s-0042-123752.
   PubMed Web of Science ®Google Scholar
• Gosselin S, Hoffman RS. The management of agitated toxidromes. Emerg Med Clin North Am. 2022;40(2):223–235. doi: 10.1016/j.emc.2022.01.009.
   PubMed Web of Science ®Google Scholar
• Richards JR, Derlet RW, Duncan DR. Methamphetamine toxicity: treatment with a benzodiazepine versus a butyrophenone. Eur J Emerg Med. 1997;4(3):130–135. doi: 10.1097/00063110-199709000-00003.
   PubMedGoogle Scholar
• Derlet RW, Rice P, Horowitz BZ, et al. Amphetamine toxicity: experience with 127 cases. J Emerg Med. 1989;7(2):157–161. doi: 10.1016/0736-4679(89)90263-1.
   PubMedGoogle Scholar
• Ruha AM, Yarema MC. Pharmacologic treatment of acute pediatric methamphetamine toxicity. Pediatr Emerg Care. 2006;22(12):782–785. doi: 10.1097/01.pec.0000245179.51535.ab.
   PubMed Web of Science ®Google Scholar
• Richards JR, Derlet RW, Duncan DR. Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol. J Emerg Med. 1998;16(4):567–573. doi: 10.1016/s0736-4679(98)00045-6.
   PubMedGoogle Scholar
• Heinzerling KG, Shoptaw S, Peck JA, et al. Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence. Drug Alcohol Depend. 2006;85(3):177–184. doi: 10.1016/j.drugalcdep.2006.03.019.
   PubMed Web of Science ®Google Scholar
• Phillips TJ, Reed C. Targeting GABAB receptors for anti-abuse drug discovery. Expert Opin Drug Discov. 2014;9(11):1307–1317. doi: 10.1517/17460441.2014.956076.
   PubMed Web of Science ®Google Scholar
• Syrjanen R, Schumann J, Fitzgerald J, et al. The emerging drugs network of Australia - Victoria clinical registry: a state-wide illicit substance surveillance and alert network. Emerg Med Australas. 2022;35(1):82–88. doi: 10.1111/1742-6723.14059.
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381. doi: 10.1016/j.jbi.2008.08.010.
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Minor BL, REDCap Consortium., et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. doi: 10.1016/j.jbi.2019.103208.
   PubMed Web of Science ®Google Scholar
• Di Rago M, Pantatan S, Hargreaves M, et al. High throughput detection of 327 drugs in blood by LC-MS-MS with automated data processing. J Anal Toxicol. 2021;45(2):154–183. doi: 10.1093/jat/bkaa057.
   PubMed Web of Science ®Google Scholar
• von Cüpper M, Dalsgaard PW, Linnet K. Identification of new psychoactive substances in seized material using UHPLC-QTOF-MS and an online mass spectral database. J Anal Toxicol. 2021;44(9):1047–1051. doi: 10.1093/jat/bkaa028.
   PubMed Web of Science ®Google Scholar
• Mardal M, Andreasen MF, Mollerup CB, et al. Corrigendum to "HighResNPS.com: an online Crowd-Sourced HR-MS database for suspect and non-targeted screening of new psychoactive substances. J Anal Toxicol. 2019;43(6):e7–e8. Erratum for: J Anal Toxicol. 2019 Aug;43:520-527. doi: 10.1093/jat/bkz049.
   PubMed Web of Science ®Google Scholar
• Wood DM, Davies S, Puchnarewicz M, et al. Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J Med Toxicol. 2010;6(3):327–330. doi: 10.1007/s13181-010-0018-5.
   PubMedGoogle Scholar
• Schep LJ, Slaughter RJ, Beasley DM. The clinical toxicology of metamfetamine. Clin Toxicol (Phila). 2010;48(7):675–694. doi: 10.3109/15563650.2010.516752.
   PubMed Web of Science ®Google Scholar
• Osman S, Zhu Z, Farag M, et al. Intracerebral hemorrhage: who gets tested for methamphetamine use and why might it matter? BMC Neurol. 2020;20(1):392. doi: 10.1186/s12883-020-01967-y.
   PubMed Web of Science ®Google Scholar
• Darke S, Duflou J, Kaye S, et al. Psychostimulant use and fatal stroke in young adults. J Forensic Sci. 2019;64(5):1421–1426. doi: 10.1111/1556-4029.14056.
   PubMed Web of Science ®Google Scholar
• Grunau BE, Wiens MO, Brubacher JR. Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review. CJEM. 2010;12(5):435–442. doi: 10.1017/s1481803500012598.
   PubMedGoogle Scholar
• Chan P, Chen JH, Lee MH, et al. Fatal and nonfatal methamphetamine intoxication in the intensive care unit. J Toxicol Clin Toxicol. 1994;32(2):147–155. doi: 10.3109/15563659409000444.
   PubMed Web of Science ®Google Scholar
• Lan KC, Lin YF, Yu FC, et al. Clinical manifestations and prognostic features of acute methamphetamine intoxication. J Formos Med Assoc. 1998;97(8):528–533.
   PubMed Web of Science ®Google Scholar
• Rusyniak DE, Sprague JE. Toxin-induced hyperthermic syndromes. Med Clin North Am. 2005;89(6):1277–1296. Erratum in: med Clin North Am. 2006;90:261-2. doi: 10.1016/j.mcna.2005.06.002.
   PubMed Web of Science ®Google Scholar
• Laskowski LK, Landry A, Vassallo SU, et al. Ice water submersion for rapid cooling in severe drug-induced hyperthermia. Clin Toxicol (Phila). 2015;53(3):181–184. doi: 10.3109/15563650.2015.1009994.
   PubMed Web of Science ®Google Scholar
• Connors NJ, Alsakha A, Larocque A, et al. Antipsychotics for the treatment of sympathomimetic toxicity: a systematic review. Am J Emerg Med. 2019;37(10):1880–1890. doi: 10.1016/j.ajem.2019.01.001.
   PubMed Web of Science ®Google Scholar
• Schep LJ, Knudsen K, Slaughter RJ, et al. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol. Clin Toxicol (Phila). 2012;50(6):458–470. doi: 10.3109/15563650.2012.702218.
   PubMed Web of Science ®Google Scholar
• Felmlee MA, Morse BL, Morris ME. γ-Hydroxybutyric acid: Pharmacokinetics, pharmacodynamics, and toxicology. Aaps J. 2021;23(1):22. doi: 10.1208/s12248-020-00543-z.
   PubMed Web of Science ®Google Scholar
• Knott JC, Taylor DM, Castle DJ. Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department. Ann Emerg Med. 2006;47(1):61–67. doi: 10.1016/j.annemergmed.2005.07.003.
   PubMed Web of Science ®Google Scholar
• Taylor DM, Yap CYL, Knott JC, et al. Midazolam-Droperidol, droperidol, or olanzapine for acute agitation: a randomized clinical trial. Ann Emerg Med. 2017;69(3):318–326.e1. doi: 10.1016/j.annemergmed.2016.07.033.
   PubMed Web of Science ®Google Scholar
• Kamal RM, van Noorden MS, Franzek E, et al. The neurobiological mechanisms of gamma-hydroxybutyrate dependence and withdrawal and their clinical relevance: a review. Neuropsychobiology. 2016;73(2):65–80. doi: 10.1159/000443173.
   PubMed Web of Science ®Google Scholar
• Barker JC, Harris SL, Dyer JE. Experiences of gamma hydroxybutyrate (gamma-hydroxybutyrate) ingestion: a focus group study. J Psychoactive Drugs. 2007;39(2):115–129. doi: 10.1080/02791072.2007.10399870.
   PubMed Web of Science ®Google Scholar
• Anderson GD. Gender differences in pharmacological response. Int Rev Neurobiol. 2008;83:1–10. doi: 10.1016/S0074-7742(08)00001-9.
   PubMed Web of Science ®Google Scholar